Wall Street brokerages predict that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will announce sales of $712.90 million for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Acadia Healthcare’s earnings. The lowest sales estimate is $708.90 million and the highest is $716.10 million. Acadia Healthcare reported sales of $702.89 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 1.4%. The firm is expected to issue its next quarterly earnings results on Thursday, February 22nd.
On average, analysts expect that Acadia Healthcare will report full year sales of $712.90 million for the current financial year, with estimates ranging from $2.82 billion to $2.83 billion. For the next financial year, analysts anticipate that the firm will report sales of $3.01 billion per share, with estimates ranging from $2.99 billion to $3.06 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. During the same quarter in the prior year, the company posted $0.58 EPS. The business’s revenue for the quarter was down 2.4% on a year-over-year basis.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at $34.01 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a twelve month low of $26.92 and a twelve month high of $54.34. The company has a market capitalization of $3,060.00, a price-to-earnings ratio of 17.35, a PEG ratio of 1.13 and a beta of 0.90.
In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $31.80, for a total transaction of $3,180,000.00. The sale was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. C M Bidwell & Associates Ltd. acquired a new stake in Acadia Healthcare during the 2nd quarter worth about $205,000. Riverhead Capital Management LLC acquired a new stake in Acadia Healthcare during the 2nd quarter worth about $209,000. State of Alaska Department of Revenue acquired a new stake in Acadia Healthcare during the 4th quarter worth about $150,000. Rathbone Brothers plc acquired a new stake in Acadia Healthcare during the 3rd quarter worth about $223,000. Finally, Shelton Capital Management acquired a new stake in Acadia Healthcare during the 2nd quarter worth about $289,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.